In the present study, we found that CHIP promotes the ubiquitin-dependent degradation of TXNIP (Figure 6), which provides new insight into the molecular mechanisms underlying the regulation of ER stress and diet-induced hepatic steatosis and demonstrates the role of CHIP as a novel therapeutic gene for treating hepatic steatosis. This evidence concerns the gene TXNIP and fatty liver disease.